SSRIs and tamoxifen. Why condemn fluoxetine?

BMJ. 2010 Mar 10:340:c1319. doi: 10.1136/bmj.c1319.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy
  • Cytochrome P-450 CYP2D6 Inhibitors
  • Depressive Disorder / drug therapy
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • Fluoxetine / therapeutic use*
  • Humans
  • Paroxetine / therapeutic use
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Cytochrome P-450 CYP2D6 Inhibitors
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Tamoxifen
  • Paroxetine